Search

Your search keyword '"FRANCISELLA tularensis"' showing total 98 results

Search Constraints

Start Over You searched for: Descriptor "FRANCISELLA tularensis" Remove constraint Descriptor: "FRANCISELLA tularensis" Topic tularemia Remove constraint Topic: tularemia Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years Publisher elsevier b.v. Remove constraint Publisher: elsevier b.v.
98 results on '"FRANCISELLA tularensis"'

Search Results

1. Current vaccine strategies and novel approaches to combatting Francisella infection.

2. Une tularémie mimant un lymphome.

3. Francisella tularensis subsp. holarctica bacteraemia in an immunocompetent male.

4. Clinical characteristics in a sentinel case as well as in a cluster of tularemia patients associated with grape harvest.

5. Glycan targeted polymeric antibiotic prodrugs for alveolar macrophage infections.

6. Anion inhibitors of the β-carbonic anhydrase from the pathogenic bacterium responsible of tularemia, Francisella tularensis.

7. Tularemia vaccine: Safety, reactogenicity, “Take” skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain – A phase 2 randomized clinical Trial.

8. Five cases of vector-borne Francisella tularensis holarctica infections in south-western Germany and genetic diversity.

9. Sulfonamide inhibition profiles of the β-carbonic anhydrase from the pathogenic bacterium Francisella tularensis responsible of the febrile illness tularemia.

10. Expansion and retention of pulmonary CD4+ T cells after prime boost vaccination correlates with improved longevity and strength of immunity against tularemia.

11. Francisella and tularemia in western Asia, Iran: a systematic review.

12. Tracking the footsteps of Francisella tularensis: Bacteriological and serological monitoring in epidemic areas in Ankara.

13. Antimicrobial activity of mosquito cecropin peptides against Francisella.

14. Cluster of ulceroglandular tularemia cases in Slovenia.

15. Phylogeography of Francisella tularensis from Tibet, China: Evidence for an asian origin and radiation of holarctica-type Tularemia.

16. Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice.

17. Tularaemia: clinical aspects in Europe.

18. A novel nanoprobe for the sensitive detection of Francisella tularensis.

19. A case report of ulceroglandular tularemia caused by Francisella tularensis subsp. Holarctica in Iran.

20. Comparison of experimental respiratory tularemia in three nonhuman primate species.

21. An overview: Tularemia and travel medicine.

22. Automated microfluidically controlled electrochemical biosensor for the rapid and highly sensitive detection of Francisella tularensis.

23. IFN-?, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.

24. Tuberculosis or tularemia? A molecular study in cervical lymphadenitis.

25. Seroepidemiological survey of tularemia among different groups in western Iran.

26. Francisella tularensis intracellular survival: to eat or to die.

27. Molecular detection of Francisella tularensis in small ruminants and their ticks in western Iran.

28. The monitoring of Francisella tularensis in surface water of East Azerbaijan province, Iran.

29. Cellular and molecular level host-pathogen interactions in Francisella tularensis: A microbial gene network study.

30. Tularemia outbreak investigations: A review.

31. Repression of Inflammasome by Francisella tularensis during Early Stages of Infection.

32. Live attenuated tularemia vaccines: Recent developments and future goals.

33. Discriminating Francisella tularensis and Francisella-like endosymbionts in Dermacentor reticulatus ticks: Evaluation of current molecular techniques

34. Examination of in vitro epithelial cell lines as models for Francisella tularensis non-phagocytic infections.

35. Temporal Transcriptional Response during Infection of Type II Alveolar Epithelial Cells with Francisella tularensis Live Vaccine Strain (LVS) Supports a General Host Suppression and Bacterial Uptake by Macropinocytosis.

36. First indication for a functional CRISPR/Cas system in Francisella tularensis.

37. Cervical lymphadenitis: tuberculosis or tularaemia? Cervical lymphadenitis: tuberculosis or tularaemia?

38. Evaluation of a commercial immunochromatographic assay for the serologic diagnosis of tularemia

39. Identification of a Novel Francisella tularensis Factor Required for Intramacrophage Survival and Subversion of Innate Immune Response.

40. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain

41. Francisella tularensis membrane complexome by blue native/SDS-PAGE

42. Immunoproteomic analysis of the human antibody response to natural tularemia infection with Type A or Type B strains or LVS vaccination.

43. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia

44. Three cases of oropharyngeal tularemia in Turkey

45. Comparative evaluation of automated and manual commercial DNA extraction methods for detection of Francisella tularensis DNA from suspensions and spiked swabs by real-time polymerase chain reaction

46. Genetic Relationship between Francisella Tularensis Strains from China and from Other Countries.

47. Histologic, immunohistochemical, microbiological, molecular biological and ultrastructural characterization of pulmonary tularemia

48. Optimal swab processing recovery method for detection of bioterrorism-related Francisella tularensis by real-time PCR

49. Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs

50. Application of electrospray ionization mass spectrometry to characterize glycerophospholipids in Francisella tularensis subsp. novicida

Catalog

Books, media, physical & digital resources